RMD (STOCKS)
ResMed Inc.
$233.950000
+5.080000 (+2.22%)
Prev close: $228.870000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael J. Farrell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $33,554.11M
- Employees
- 10,600
- P/E (TTM)
- 22.62
- P/B (TTM)
- 5.27
- Dividend Yield
- 101.80%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $5.40B |
| Benefits Costs and Expenses | $3.58B |
| Cost Of Revenue | $2.11B |
| Costs And Expenses | $3.58B |
| Gross Profit | $3.29B |
| Nonoperating Income/Loss | -$317.00K |
| Operating Expenses | $1.47B |
| Selling, General, and Administrative Expenses | $1.05B |
| Research and Development | $348.68M |
| Other Operating Expenses | $70.32M |
| Operating Income/Loss | $1.82B |
| Income/Loss Before Equity Method Investments | $1.81B |
| Income/Loss From Continuing Operations After Tax | $1.49B |
| Income/Loss From Continuing Operations Before Tax | $1.82B |
| Income/Loss From Equity Method Investments | $4.61M |
| Income Tax Expense/Benefit | $332.81M |
| Net Income/Loss | $1.49B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $1.49B |
| Net Income/Loss Available To Common Stockholders, Basic | $1.49B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $10.16 |
| Diluted Earnings Per Share | $10.11 |
| Basic Average Shares | 292,650,000 |
| Diluted Average Shares | 293,761,000 |
| Assets | $8.50B |
| Current Assets | $3.82B |
| Inventory | $922.05M |
| Other Current Assets | $2.90B |
| Noncurrent Assets | $4.68B |
| Fixed Assets | $564.25M |
| Other Non-current Assets | $4.12B |
| Liabilities | $2.18B |
| Current Liabilities | $1.25B |
| Accounts Payable | $250.41M |
| Other Current Liabilities | $997.71M |
| Noncurrent Liabilities | $934.38M |
| Long-term Debt | $403.92M |
| Other Non-current Liabilities | $530.45M |
| Equity | $6.32B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.32B |
| Liabilities And Equity | $8.50B |
| Net Cash Flow From Operating Activities | $1.91B |
| Net Cash Flow From Operating Activities, Continuing | $1.91B |
| Net Cash Flow From Investing Activities | -$269.02M |
| Net Cash Flow From Investing Activities, Continuing | -$269.02M |
| Net Cash Flow From Financing Activities | -$796.58M |
| Net Cash Flow From Financing Activities, Continuing | -$796.58M |
| Exchange Gains/Losses | $46.23M |
| Net Cash Flow | $895.13M |
| Net Cash Flow, Continuing | $848.89M |
| Comprehensive Income/Loss | $1.75B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.75B |
| Other Comprehensive Income/Loss | -$10.86M |